This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The $6.3 trillion wellness industry thrives on distrust of science, glorifying “natural” alternatives, and fear-based marketing. The result? Pseudoscience that’s not just harming human health. It’s killing animals, too, specifically via H5N1 bird flu. Holistic pet health influencers, organic farmers, and alternative medicine advocates embrace behaviors that increase the risk of viral transmission, paving the way for a potential human pandemic.
Dosium Touchdose has gone live at West Middlesex University Hospital, UK, a clinical decision support technology proven to significantly reduce prescribing errors. This follows go-live at both Chelsea and Westminster Hospital last month, and St Marys Hospital last summer, marking the final stage of rollout across the entire West London Childrens Healthcare (WLCH) partnership.
Mark Ratain’s First Opinion piece of Feb. 4, 2025 , implies that the oncologists in NCI’s Investigational Drug Branch (IDB) colluded with the drug company Exilixis to sponsor two Phase 3 studies of its drug cabozantanib. He claims these studies showed minimal benefit, yet the results were used to inflate the value of Exilixis stock. Ratain concludes by recommending that IDB be abolished.
OneSource Specialty Pharma has announced that its Unit 2 manufacturing facility in Bengaluru has received Good Manufacturing Practices (GMP) certification from ANVISA, the Brazilian Health Regulatory Agency. The approval follows a successful regulatory inspection conducted in November 2024. The certification permits OneSource to expand its reach into Brazil, supporting clients preparing for product registration and market entry.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences should issue compulsory licenses if the company fails to modify an existing licensing program with half a dozen generic makers. In an essay in Clinical Infectious Diseases , they complained Gilead pursued voluntary licenses that are too restrictive, which will delay or deny access to its drug.
TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the progression of Alzheimer’s disease over a period of at least 18 months. If approved by regulators, HMTM could be the first oral treatment for the disease that targets the tau protein. Conventionally, targeted therapies for Alzheimers focused on amyloid protein […] The post Research finds tablet effective in slowing progression of Alzheimers disease over 18 months appeared f
59
59
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the progression of Alzheimer’s disease over a period of at least 18 months. If approved by regulators, HMTM could be the first oral treatment for the disease that targets the tau protein. Conventionally, targeted therapies for Alzheimers focused on amyloid protein […] The post Research finds tablet effective in slowing progression of Alzheimers disease over 18 months appeared f
NEW YORK — A top Centers for Disease Control and Prevention official told staff this week to start planning for the agency’s splintering. Several parts of CDC — mostly those devoted to health threats that aren’t infectious — are being spun off into the soon-to-be-created Administration for a Healthy America, the agency official told senior leaders in calls and meetings.
NHC Statement on Fiscal Year 2026 Federal Health Care Funding NHC Statement on Fiscal Year 2026 Federal Health Care Funding (PDF) Prepared written testimony for Kimberly Beer Senior Vice President, Policy and External Affairs, National Health Council U.S. House of Representatives, Committee on Appropriations Subcommittee on Labor, Health and Human Services, and Education April 9, 2025 Thank you for the opportunity to submit testimony in support of Fiscal Year 2026 appropriations that place patie
There is worldwide concern around the use of PFAS. In the EU, a joint PFAS Restriction Proposal under REACH was submitted, aiming for a full ban by 2028/2030. This poses a significant challenge for pharmaceutical manufacturers, not least because of the technical challenges related to operations, supply chain and the environment. This article explores the potential impact of the proposal and considers how manufacturers can ensure the safety and reliability of their products.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
AAX Biotech has appointed Ionut Gabriel Dumitru (pictured left) as senior scientist and Kushal Sejwal (pictured right) as business developer, contributing to its strategy to develop its research and business. The company experiences growing interest in its Seqitope and Opti-mAb technologies, platforms pioneering its mission to develop innovative antibody therapeutics.
Tariffs Are Here: What European Automakers Must Do To Stay Competitive priyanka.katke Thu, 04/10/2025 - 19:55 European automakers in the U.S. just hit a major tariff roadblock. This isnt just about added costs its a detour that risks supply disruption, weaker demand, and shrinking margins. GEPs latest bulletin breaks down what the tariff changes mean for EU automakers operating in the U.S. market, and what they can do right now.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Experts say the layoffs are already causing issues in drug development — and things may get far worse without critical institutional knowledge at the FDA.
Granules India has announced the completion of its acquisition of Switzerland-based Contract Development and Manufacturing Organisation (CDMO), Senn Chemicals AG. Prior to this announcement, in February 2025, Granules India had stated its intention to enter the CDMO business through the acquisition of Senn Chemicals AG for 192.5 crore. Granules acquired 100 per cent of the equity of Senn Chemicals from the founding Senn family.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Morepen Laboratories has announced a strategic plan to expand its domestic salesforce by more than 1,000 professionals over the next three years. As part of the initiative, over 200 team members are expected to be added in FY26 alone. The move is aimed at strengthening the companys formulations business and enhancing its reach across doctors, pharmacies, patients, and other healthcare professionals.
Pharmaceutical Technology Group spoke with Erik Wiklund, CEO of Circio, about the impact of the post-COVID-19 world on the pharmaceutical industry and how that has shifted the talent pool.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
The PharmTech Group interviewed Edwin Stone, CEO of Cellular Origins, about the bio/pharmaceutical trends from 2024 that continue to impact the industry in 2025.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
These days, the same big health care conglomerate could own your PBM, insurer, pharmacy and even your doctor’s office. Middlemen now control what medicines you can get, what you pay at the pharmacy counter, what pharmacy you can you use and what hoops you must jump through to get the medicine your doctor prescribed.
What makes a pharma brand stand out in todays noisy, regulated digital space? Its not just about having a website or running banner ads. Its about building a connected, compliant, and patient-centric experience across all touchpoints. For pharmaceutical marketing executives, embedding the right digital marketing strategies into annual plans is no longer optionalits a strategic necessity.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
364 
Let's personalize your content